2-((3S,14S,15S,E)-15-((R)-hexadecan-2-yl)-7,14-dimethyl-11-methylene-2,5,8,13-tetraoxo-1-oxa-4,7,12-triazacyclopentadec-9-en-3-yl)-N-methylacetamide

ID: ALA4161330

Chembl Id: CHEMBL4161330

PubChem CID: 145959916

Max Phase: Preclinical

Molecular Formula: C33H56N4O6

Molecular Weight: 604.83

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1/C=C/C(=O)N(C)CC(=O)N[C@@H](CC(=O)NC)C(=O)O[C@@H]([C@H](C)CCCCCCCCCCCCCC)[C@H](C)C(=O)N1

Standard InChI:  InChI=1S/C33H56N4O6/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-24(2)31-26(4)32(41)35-25(3)20-21-30(40)37(6)23-29(39)36-27(33(42)43-31)22-28(38)34-5/h20-21,24,26-27,31H,3,7-19,22-23H2,1-2,4-6H3,(H,34,38)(H,35,41)(H,36,39)/b21-20+/t24-,26+,27+,31+/m1/s1

Standard InChI Key:  OYMWBXKCLOIUFE-BBVFDWHOSA-N

Alternative Forms

  1. Parent:

    ALA4161330

    ---

Associated Targets(Human)

PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ASPC1 (1310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PaTu 8988t (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 604.83Molecular Weight (Monoisotopic): 604.4200AlogP: 4.54#Rotatable Bonds: 16
Polar Surface Area: 133.91Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.02CX Basic pKa: CX LogP: 4.64CX LogD: 4.64
Aromatic Rings: Heavy Atoms: 43QED Weighted: 0.17Np Likeness Score: 0.78

References

1. Chen J, Li J, Wu L, Geng Y, Yu J, Chong C, Wang M, Gao Y, Bai C, Ding Y, Chen Y, Zhang Q..  (2018)  Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.,  151  [PMID:29656202] [10.1016/j.ejmech.2018.03.078]

Source